Gitte Aabo has become chief executive officer (CEO) of LEO Pharma A/S of Denmark, succeeding Ernst Lunding who has become the company’s chairman and head of the LEO Foundation. The appointments took effect 1 January 2008.
Ms Aabo has worked for LEO since 1992, most recently as deputy chief executive. Previously she was executive vice president for finance and IT.
LEO Pharma is a research-based pharmaceutical company which focuses on the development, manufacture and marketing of treatments for skin diseases, including psoriasis. LEO Pharma is wholly owned by the LEO Foundation.
Source:
Leo Pharmat press release, 2 January 2008
Copyright 2008 Evernow Publishing Ltd